Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

Phase

N/A

Condition

Stimulant Use Disorder

Opioid Use Disorder

Treatment

Text Message Check-ins

Contingency Management

Clinical Study ID

NCT05897788

853153

Ages > 18
All Genders
Accepts Healthy Volunteers

Study Summary

There is growing recognition of the need for approaches to initiate treatment wherever patients touch the health care system, including the Emergency Department (ED). Most research has focused on initiation of medications for opioid use disorder (MOUDs) in the ED rather than ensuring continued treatment post-discharge. The investigators propose to adapt evidence-based interventions to support patients' complex needs and facilitate continued treatment, rather than discharging them and having them navigate outpatient treatment systems with limited support. The research team will randomize participants into 1 of 4 arms to receive varying degrees of augmented usual care, including daily check-ins and contingency management. The investigators plan to examine the effects of check-ins and contingency management on engagement with addiction treatment and equity of treatment effects among racial and ethnic subgroups and assess important moderators of treatment effects.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Participants must be 18 or older
Screen positive for OUD
Bridge buprenorphine prescription (emergency department (ED) enrollment -Buprenorphine prescription at ED discharge; Bridge clinic enrollment - newbuprenorphine prescription associated with on-demand or drop-in encounter
English reading ability
Have a mobile phone capable of receiving text messages

Exclusion

Exclusion Criteria:

Not being up to date with requirements above

Study Design

Text Message Check-ins

March 20, 2024

November 30, 2026

Study Description

The investigators are proposing to conduct a randomized controlled trial to determine the effectiveness of various text-based and contingency management interventions on Opioid Use Disorder patients. Our goals are to measure their engagement with recovery treatment. The research team plan to enroll 1,649 participants into one of the following 4 arms.

Patients enrolled into the Way to Health CareConnect text line as part of usual care and meeting eligibility criteria will be enrolled in this randomized control trial and randomized to:

Augmented usual care (standard Way to HealthCareConnect text line) Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week.

Augmented usual care + text-message check-ins (standard Way to Health CareConnect Text line) Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week AND (text-message check-ins) patients will receive automated text-message check-ins up to once per day for 30 days to see if the patient needs help with anything.

Augmented usual care + contingency management (standard Way to Health CareConnect Text line) and, participants will be compensated for going to their follow-up appointments.

Augmented usual care + CM + Text-message check-ins (standard Way to Health CareConnect text line) AND text-message check-ins-patients will receive automated text-message check-ins up to once per day for 30 days to see if the patient needs help with anything AND, participants will receive compensation for attending their follow-up appointments.

Patients enrolled in the trial will also be invited to complete the intake survey and follow-up surveys. Patients will receive financial compensation for completing these surveys. The study team plans to enroll 1,649 participants for this study.

Connect with a study center

University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.